| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |